The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review

Psoriasis is a chronic immune-mediated inflammatory disease affecting women of childbearing potential. Biologic agents, notably Tumor Necrosis Factor inhibitors (TNFi), are the only current non-contraindicated systemic treatment option during pregnancy. TNFi comprised of complete immunoglobulin G (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansen, Cæcilie Bachdal, Jimenez-Solem, Espen, Haerskjold, Ann, Sand, Freja Lærke, Thomsen, Simon Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983707/
https://www.ncbi.nlm.nih.gov/pubmed/29751529
http://dx.doi.org/10.3390/ijms19051349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983707/
https://www.ncbi.nlm.nih.gov/pubmed/29751529
http://dx.doi.org/10.3390/ijms19051349

Ejemplares similares